TA

Tanvir Anjum Laskar

Active Director Director DIN 09394760
DIN 09394760 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Tanvir Anjum Laskar

Data last updated:

Tanvir Anjum Laskar is a Director at Unolyn Pharma International Private Limited (since 2022) and Director at Acure Pharma Private Limited (since 2021). The companies operate in Chemicals.

DIN 09394760
Primary Designation Director
Industry Chemicals
First Appointment 22 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20222022Active
Acure Pharma Private Limited U24299WB2021PTC249731
Director22 Nov 20212021Active

Directorship timeline

Open interactive timeline →
Unolyn Pharma International Private Limited
Acure Pharma Private Limited
Premium access

Shareholding and investment profile for Tanvir Anjum Laskar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tanvir Anjum Laskar

Tanvir Anjum Laskar currently holds 2 directorships: Unolyn Pharma International Private Limited (Director, since 19 Jan 2022); Acure Pharma Private Limited (Director, since 22 Nov 2021).

Tanvir Anjum Laskar was first appointed on 22 Nov 2021 as Director at Acure Pharma Private Limited. The most recent appointment on record is 19 Jan 2022 at Unolyn Pharma International Private Limited.

The current boards of Tanvir Anjum Laskar's companies include Izaz Ahmed Gazi (Unolyn Pharma International Private Limited), Md Sadique Islam (Unolyn Pharma International Private Limited), Mohammed Najib Ahmed (Unolyn Pharma International Private Limited), Rabiul Hoque Molla (Acure Pharma Private Limited), Sabina Yeasmin (Acure Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available